Literature DB >> 16877262

Possible drug-metabolism interactions of medicinal herbs with antiretroviral agents.

Carolien J P van den Bout-van den Beukel1, Peter P Koopmans, André J A M van der Ven, Peter A G M De Smet, David M Burger.   

Abstract

Herbal medicines are widely used by HIV patients. Several herbal medicines have been shown to interact with antiretroviral drugs, which might lead to drug failure. We have aimed to provide an overview of the modulating effects of Western and African herbal medicines on antiretroviral drug-metabolizing and transporting enzymes, focusing on potential herb-antiretroviral drug interactions. Echinacea, garlic, ginkgo, milk thistle, and St. John's wort have the potential to cause significant interactions. In vitro and in vivo animal studies also indicated other herbs with a potential for interactions; however, most evidence is based on in vitro studies. Further pharmacokinetic studies to unveil potential Western and especially African herb-antiretroviral drug interactions are urgently required, and the clinical significance of these interactions should be assessed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877262     DOI: 10.1080/03602530600754065

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  19 in total

1.  Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines.

Authors:  Alice Tseng; Michelle Foisy; Christine A Hughes; Deborah Kelly; Shanna Chan; Natalie Dayneka; Pierre Giguère; Niamh Higgins; Cara Hills-Nieminen; Jeff Kapler; Charles J L la Porte; Pam Nickel; Laura Park-Wyllie; Carlo Quaia; Linda Robinson; Nancy Sheehan; Shannon Stone; Linda Sulz; Deborah Yoong
Journal:  Can J Hosp Pharm       Date:  2012-03

2.  Effect of ginkgo biloba on the pharmacokinetics of raltegravir in healthy volunteers.

Authors:  Maren Blonk; Angela Colbers; Anne Poirters; Bas Schouwenberg; David Burger
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

3.  Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir.

Authors:  R A B van Waterschoot; R ter Heine; E Wagenaar; C M M van der Kruijssen; R W Rooswinkel; A D R Huitema; J H Beijnen; A H Schinkel
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 4.  Traditional, complementary, and alternative medical cures for HIV: rationale and implications for HIV cure research.

Authors:  Xin Pan; Alice Zhang; Gail E Henderson; Stuart Rennie; Chuncheng Liu; Weiping Cai; Feng Wu; Joseph D Tucker
Journal:  Glob Public Health       Date:  2017-12-13

5.  Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.

Authors:  Alice Tseng; Michelle Foisy
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 6.  Interactions between herbal medicines and prescribed drugs: an updated systematic review.

Authors:  Angelo A Izzo; Edzard Ernst
Journal:  Drugs       Date:  2009       Impact factor: 9.546

7.  Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics.

Authors:  Bill J Gurley; Ashley Swain; D Keith Williams; Gary Barone; Sunil K Battu
Journal:  Mol Nutr Food Res       Date:  2008-07       Impact factor: 5.914

Review 8.  Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.

Authors:  Francesca Borrelli; Angelo A Izzo
Journal:  AAPS J       Date:  2009-10-27       Impact factor: 4.009

9.  Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women.

Authors:  Chenglong Liu; Yang Yang; Stephen J Gange; Kathleen Weber; Gerald B Sharp; Tracey E Wilson; Alexandra Levine; Esther Robison; Lakshmi Goparaju; Monica Gandhi; Monica Ganhdi; Dan Merenstein
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

Review 10.  Drug-drug interactions during antiviral therapy for chronic hepatitis C.

Authors:  Jennifer J Kiser; James R Burton; Gregory T Everson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.